Print page content Print
Increase text size Decrease text size
Text Size

Zoetis discontinued the sale of MITABAN on July 31, 2018. For treatment alternatives, please reach out to your local Zoetis Veterinary Professional Services representative or our Zoetis product help line.


An effective treatment for D. canis


MITABAN is indicated for acaricidal treatment of generalized demodicosis (D. canis) in dogs. Current data do not support use for treatment of localized demodicosis or scabies.

Collapse All
    • Proven efficacy for indicated conditions.
    • Product dating assures potency.
    • Long-standing initial treatment of choice.
    Long and medium-haired dogs should be clipped closely before treating. Prior to the initial treatment, all dogs should be bathed with a mild soap and water and towel dried. The entire animal should then be topically treated with MITABAN (amitraz) at a rate of 10.6 milliliters (contents of one bottle) per 2 gallons of warm water (250 ppm active drug). Two bottles (21.2 milliliters) per four gallons of water may be necessary to treat large dogs. The entire dog should be thoroughly and completely wetted with the mixture, and then allowed to air dry. Do not rinse or towel dry the dog after treatment with MITABAN. A fresh MITABAN-water mixture should be prepared for each patient; using the same mixture for more than one patient can spread other dermal infections and also the concentration of MITABAN could be reduced to a level which would be less effective than the recommended concentration.

    Three to six topical treatments (14 days apart) are recommended for the treatment of generalized demodicosis. It is important to continue treatment until no viable (alive) mites are found in the skin scrapings at two successive treatments, or until six treatments have been applied. Severe (chronic) cases and dogs which are reinfested may require a second and third series of treatments, and again the treatment should be applied at 14 day intervals. Discontinue treatment of dogs which do not respond clinically.

    When using MITABAN for treatment of demodicosis, other dogs in the home also should be examined for lesions to ascertain whether treatment of these animals is warranted.

IMPORTANT SAFETY INFORMATION: MITABAN may alter the ability to maintain homeostasis. Animals treated with this product should not be subjected to stress for a period of at least 24 hours post treatment. Adverse reactions including fatalities have been reported. Transient sedation may occur after treatment with this product. Safety for pregnant animals or dogs less than four months of age has not been established. Wash hands and arms with soap and water after treatment. Avoid handling pets immediately after treatment. Contact may cause skin irritation in sensitive individuals during the first few days after treatment. Ingestion or inhalation may cause central nervous system depression. Dispose of unused solution by flushing down the drain. Rinse the MITABAN container with water and do not reuse.

For more safety information, please refer to the full Prescribing Information.




Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.